Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”

Detalles Bibliográficos
Autores principales: Godman, Brian, Wladysiuk, Magdalene, McTaggart, Stuart, Kurdi, Amanj, Allocati, Eleonora, Jakovljevic, Mihajlo, Kalemeera, Francis, Hoxha, Iris, Nachtnebel, Anna, Sauermann, Robert, Hinteregger, Manfred, Marković-Peković, Vanda, Tubic, Biljana, Petrova, Guenka, Tachkov, Konstantin, Slabý, Juraj, Nejezchlebova, Radka, Krulichová, Iva Selke, Laius, Ott, Selke, Gisbert, Langner, Irene, Harsanyi, András, Inotai, András, Jakupi, Arianit, Henkuzens, Svens, Garuolienė, Kristina, Gulbinovič, Jolanta, Bonanno, Patricia Vella, Rutkowski, Jakub, Ingeberg, Skule, Melien, Øyvind, Mardare, Ileana, Fürst, Jurij, MacBride-Stewart, Sean, Holmes, Carol, Pontes, Caridad, Zara, Corinne, Pedrola, Marta Turu, Hoffmann, Mikael, Kourafalos, Vasileios, Pisana, Alice, Banzi, Rita, Campbell, Stephen, Wettermark, Bjorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104731/
https://www.ncbi.nlm.nih.gov/pubmed/37065720
http://dx.doi.org/10.1155/2023/9757348

Ejemplares similares

Ejemplares similares